Michiels S - Search Results

1

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.

Michiels S, Le Maître A, Buyse M, Burzykowski T, Maillard E, Bogaerts J, Vermorken JB, Budach W, Pajak TF, Ang KK, Bourhis J, Pignon JP; MARCH and MACH-NC Collaborative Groups. Michiels S, et al. Lancet Oncol. 2009 Apr;10(4):341-50. doi: 10.1016/S1470-2045(09)70023-3. Epub 2009 Feb 24. Lancet Oncol. 2009. PMID: 19246242

2

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.

Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Planchard D, et al. Among authors: michiels s. Cancer. 2004 Jan 1;100(1):28-35. doi: 10.1002/cncr.11881. Cancer. 2004. PMID: 14692021 Free article.

3

Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.

Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Among authors: michiels s. JAMA. 2004 Jul 28;292(4):470-84. doi: 10.1001/jama.292.4.470. JAMA. 2004. PMID: 15280345

4

Prediction of cancer outcome with microarrays: a multiple random validation strategy.

Michiels S, Koscielny S, Hill C. Michiels S, et al. Lancet. 2005 Feb 5-11;365(9458):488-92. doi: 10.1016/S0140-6736(05)17866-0. Lancet. 2005. PMID: 15705458

5

Meta-analysis when only the median survival times are known: a comparison with individual patient data results.

Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP. Michiels S, et al. Int J Technol Assess Health Care. 2005 Winter;21(1):119-25. doi: 10.1017/s0266462305050154. Int J Technol Assess Health Care. 2005. PMID: 15736523

6

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.

Fizazi K, Le Maitre A, Hudes G, Berry WR, Kelly WK, Eymard JC, Logothetis CJ, Pignon JP, Michiels S; Meta-analysis of Estramustine in Prostate Cancer (MECaP) Trialists' Collaborative Group. Fizazi K, et al. Among authors: michiels s. Lancet Oncol. 2007 Nov;8(11):994-1000. doi: 10.1016/S1470-2045(07)70284-X. Epub 2007 Oct 17. Lancet Oncol. 2007. PMID: 17942366

7

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.

Delbaldo C, Michiels S, Rolland E, Syz N, Soria JC, Le Chevalier T, Pignon JP. Delbaldo C, et al. Among authors: michiels s. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004569. doi: 10.1002/14651858.CD004569.pub2. Cochrane Database Syst Rev. 2007. PMID: 17943820 Updated. Review.

8

Progression-free survival is a surrogate for survival in advanced colorectal cancer.

Buyse M, Burzykowski T, Carroll K, Michiels S, Sargent DJ, Miller LL, Elfring GL, Pignon JP, Piedbois P. Buyse M, et al. Among authors: michiels s. J Clin Oncol. 2007 Nov 20;25(33):5218-24. doi: 10.1200/JCO.2007.11.8836. J Clin Oncol. 2007. PMID: 18024867

9

Individual- and trial-level surrogacy in colorectal cancer.

Buyse M, Burzykowski T, Michiels S, Carroll K. Buyse M, et al. Among authors: michiels s. Stat Methods Med Res. 2008 Oct;17(5):467-75. doi: 10.1177/0962280207081864. Epub 2008 Feb 19. Stat Methods Med Res. 2008. PMID: 18285439

10

Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.

André F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S. André F, et al. Among authors: michiels s. Lancet Oncol. 2009 Apr;10(4):381-90. doi: 10.1016/S1470-2045(09)70024-5. Epub 2009 Feb 25. Lancet Oncol. 2009. PMID: 19249242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page